Lorundrostat LAUNCH-HTN Trial

from Future Pulse Cardiology Hosted by Dr Thomas Nero Dr Liffert Vogt

We would love to hear your thoughts on the episodes! Dr Thomas Nero discusses the new aldosterone synthase inhibitor Lorundrostat with Dr Liffert Vogt and the outcomes from the Launch HTN trial.

Episode details come from the podcast's RSS feed.

Embed this episode

Attribution link and audio player

Ready to play

Lorundrostat LAUNCH-HTN Trial

0:00 20:40

No transcript yet.

Requests help us decide what to transcribe next.

Share this episode

Similar podcasts

The Course Mentors Podcast The Course Mentors Hey there, future course creator! Ever feel like turning your know-how into an online course is like trying to solve a Rubik's cube blindfolded? Well, grab your headphones because "The Course Mentors Podcast" is here to be your secret weapon! Meet Aimee and Odette (that's us!), your new best friends in the course creation world. We've been in the trenches for over a decade, and for the last five years, we've been rocking the online course space. Now we're here to spill all our secrets in bite-sized, 15-20 minute episodes that'll fit perfectly in your coffee breaks. No fluff, no filler - just real, actionable advice that'll take you from "um, what's a landing page?" to "holy moly, I just hit six figures!". We're talking everything from crafting your course to marketing it like a pro and building a business that'll have you pinching yourself. Whether you're dreaming of ditching the 9-to-5 grind, adding a sweet extra income str

Frequently asked questions

How long is this episode of Future Pulse Cardiology?

This episode is 20 minutes long.

When was this Future Pulse Cardiology episode published?

This episode was published on July 29, 2026.

Can I download this Future Pulse Cardiology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.